Katherine W. Reeves
B.S., Yale University, 2002; M.P.H., The Ohio State University, 2003; Ph.D., University of Pittsburgh, 2008
Cancer epidemiology, women's health, breast cancer, endocrine disruption
My research seeks to identify modifiable risk factors for breast cancer, with the ultimate goal of reducing breast cancer morbidity and mortality. Specifically, my research focuses on modifiable factors that may mediate breast cancer risk through hormonal pathways, including depression and/or antidepressant use, endocrine-disrupting chemicals such as bisphenol-A (BPA) or phthalates, and obesity and metabolic disease. I seek to understand how these factors may impact breast cancer risk and mammographic density (a strong breast cancer risk factor).
Houghton SC, Reeves KW, Hankinson SE, Crawford L, Lane D, Wactawski-Wende J, Thomson C, Ockene J, Sturgeon SR. Perineal powder use and risk of ovarian cancer. Journal of the National Cancer Institute. In press.
Sturgeon SR, Doherty A, Reeves KW, Bigelow C, Stancyzk FZ, Ockene JK, Liu S, Manson JE, Neuhouser ML. Urinary levels of melatonin and risk of postmenopausal breast cancer: Women’s Health Initiative Observational Cohort. Cancer Epidemiology Biomarkers and Prevention. 2014; 23(4):629-637.
Hudson AG, Reeves KW, Modugno F, Wilson JW, Evans RW, Vogel VG, Gierach GL, Simpson J, Weissfeld JL. Erythrocyte omega-6 and omega-3 fatty acids and mammographic breast density. Nutrition and Cancer. 2013; 65(3):410-6.
Reeves KW, Bacon K, Fredman L. Caregiving associated with selected cancer risk behaviors and screening utilization among women: cross-sectional results of the 2009 BRFSS. BMC Public Health. 2012; 12(1):685.
Reeves KW, McLaughlin V, Fredman L, Ensrud KE, Cauley JA. Components of Metabolic Syndrome and Risk of Breast Cancer by Prognostic Features in the Study of Osteoporotic Fractures Cohort. Cancer Causes and Control. 2012; 23(8):1241-1251.